PEAL Capital Partners is a female-founded, European based, lower midcap private equity firm specializing in control investments within the rapidly growing sector of Longevity and Hormones (“L&H”). The senior team have worked together since 2006 and built up a strong track record across multiple economic cycles and regions. Leveraging our extensive family office network and Medical Panel, PEAL researches and sources companies in the areas of male and female hormones, blood testing and pharmacy to support longevity-focused training and clinical services. We find that this methodology creates sustainable business models with attractive rewards for the portfolio companies and the investors.
Company Details
- Employees
- 11
- Founded
- -
- Address
- 2 Portman Street, London,england W1h 6du,united Kingdom
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- pealinvestments.com
- Keywords
- London.
- HQ
- London, England
Peal Capital Group Questions
Peal Capital Group's website is pealinvestments.com
Peal Capital Group's LinkedIn profile is https://uk.linkedin.com/company/pealcapitalgroup
Peal Capital Group has
11 employees.
View email and phone details for 11
employees at Peal Capital Group.
Peal Capital Group's industry is
Investment Management
Peal Capital Group's top competitors are
Lcm Partners,
Longevity Investors,
Peal Capital,
Apex Medical Academy,
Ara Partners,
Hsbc Innovation Banking,
Kidd & Company,
Eutelsat Oneweb,
Dermamedical,
Buy And Build.
Peal Capital Group's categories are Investment Management
Peal Capital Group's founding year is 2014
